BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 8104901)

  • 1. T-cell recognition of a cross-reactive antigen(s) in erythrocyte stages of Plasmodium falciparum and Plasmodium yoelii: inhibition of parasitemia by this antigen(s).
    Lucas B; Engels A; Camus D; Haque A
    Infect Immun; 1993 Nov; 61(11):4863-9. PubMed ID: 8104901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium yoelii in mice: antigen reactivity of CD4- and CD8-bearing T cells.
    Lucas B; Engel A; Camus D; Haque A
    Cell Immunol; 1993 Aug; 150(1):59-71. PubMed ID: 8102089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth.
    Ray P; Sahoo N; Singh B; Kironde FA
    Infect Immun; 1994 Jun; 62(6):2354-61. PubMed ID: 8188358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo.
    Brahimi K; Badell E; Sauzet JP; BenMohamed L; Daubersies P; Guérin-Marchand C; Snounou G; Druilhe P
    Infect Immun; 2001 Jun; 69(6):3845-52. PubMed ID: 11349050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
    Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
    Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice immunised with synthetic peptide from N-terminal conserved region of merozoite surface antigen-2 of human malaria parasite Plasmodium falciparum can control infection induced by Plasmodium yoelii yoelii 265BY strain.
    Lougovskoi AA; Okoyeh NJ; Chauhan VS
    Vaccine; 1999 Dec; 18(9-10):920-30. PubMed ID: 10580206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ and CD8+ T lymphocytes both contribute to acquired immunity to blood-stage Plasmodium chabaudi AS.
    Podoba JE; Stevenson MM
    Infect Immun; 1991 Jan; 59(1):51-8. PubMed ID: 1898902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
    Xu L; Pei X; Berzins K; Chaudhuri A
    Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
    Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice.
    Sharma SK; Farah D; Misra-Bhattacharya S; Bajpai P; Agarwal A; Mohammad O
    Vaccine; 2006 Feb; 24(7):948-56. PubMed ID: 16168527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
    Sauzet JP; Perlaza BL; Brahimi K; Daubersies P; Druilhe P
    Infect Immun; 2001 Feb; 69(2):1202-6. PubMed ID: 11160023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic peptides based on conserved Plasmodium falciparum antigens are immunogenic and protective against Plasmodium yoelii malaria.
    Chauhan VS; Chatterjee S; Johar PK
    Parasite Immunol; 1993 Apr; 15(4):239-42. PubMed ID: 7685076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical efficacy and immunogenicity assessment to show that a chimeric Plasmodium falciparum UB05-09 antigen could be a malaria vaccine candidate.
    Dinga JN; Gamua SD; Ghogomu SM; Titanji VPK
    Parasite Immunol; 2018 Mar; 40(3):. PubMed ID: 29284177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
    Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
    J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Novel CD4
    Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR
    J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TGF-beta and PGE2 in T cell responses during Plasmodium yoelii infection.
    Ocaña-Morgner C; Wong KA; Lega F; Dotor J; Borras-Cuesta F; Rodriguez A
    Eur J Immunol; 2007 Jun; 37(6):1562-74. PubMed ID: 17474154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
    J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide.
    Rénia L; Marussig MS; Grillot D; Pied S; Corradin G; Miltgen F; Del Giudice G; Mazier D
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7963-7. PubMed ID: 1680235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of T-cell responses in malaria-exposed and non-exposed donors using Plasmodium falciparum asexual blood stages enriched by a simple centrifugation method.
    Farouk SE; Shen J; Tangteerawatana P; Bolad A; Berzins K; Troye-Blomberg M
    Acta Trop; 2006 Jan; 97(1):42-9. PubMed ID: 16280120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.